Charles Levenback, MD

The University of Texas MD Anderson Cancer Center

LevenbackDr. Levenback is Professor and Deputy Chair for Patient Care and the Gynecologic Oncology Center Medical Director in the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas M.D. Anderson Cancer Center.

Dr. Levenback joined the faculty in 1989 after completing fellowship training at Memorial Sloan Kettering Cancer Center in New York City.  Dr. Levenback is recognized as a clinical leader as Deputy Chairman of the Department of Gynecologic Oncology and Reproductive Medicine as well as Medical Director of the Gynecologic Oncology Center.  He has been instrumental in doubling the size of the Gynecologic Oncology Center practice while incorporating strategies to improve clinical effectiveness and safety.  Dr. Levenback has received several M.D. Anderson recognition awards for his skill as an educator and communicator, and he is currently ranked as the Top Doctors for Gynecologic Oncology in U.S. News & World Report.  Dr. Levenback has an international reputation for the development of sentinel lymph node biopsy in patients with gynecologic cancer and serves as a member of several organizations, including the Board of Directors for The American College of Obstetricians and Gynecologists, the Steering Committee for the Council on Patient Safety in Women’s Health Care in Washington, DC, The Gynecologic Oncology Group Ovarian Committee and chairs the Surgery Safety Committee at M.D. Anderson Cancer Center.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.